About Jeffrey Chi
Jeffrey Chi is a director at Aardvark Therapeutics.
Jeffrey Chi reports to the SEC as a director, officer or major shareholder of 2 public companies, including Scilex Holding (SCLX).
Jeffrey Chi first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Chi in the role, so the role may have started earlier or lasted longer.
SC
Scilex Holding Co
Officer and director and 10% owner
2021 – 2022 · Public company (SCLX)
Key Colleagues at Startups
The people Jeffrey Chi works with at each company, as listed on that company's latest Form D.
Aardvark Therapeutics, Inc. · Form D, May 15, 2024